Search results
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most recent filing ...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 6 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 4 days agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 6 days agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 4 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345.
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 7 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...
Moderna to Present at Upcoming Conferences in May/June 2024
The Joplin Globe· 4 days agoA replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation. Moderna is a leader in the creation of the ...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 7 days agoModerna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial ...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 6 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...